GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: compound 1 [WO2022017494]
Compound class:
Synthetic organic
Comment: Socrodeucitinib is the INN for a (deuterated) Janus kinase inhibitor with anti-inflammatory potential (included in WHO INN proposed list 133, 10th July 2025). The structure is claimed as compound 1 in patent WO2022017494A1 (Hansoh Biopharmaceutical), and is proposed as a TYK2 inhibitor [1]. Hansoh have TYK2 inhibitor HS-10374 in phase 2 and 3 clinical trials for psoriatic arthritis and psoriasis, but we are unable to confirm a name-to-structure match at this time (July 2025).
|
|
|||||||||||||||||||||||||||||||||||
Classification ![]() |
|
| Compound class | Synthetic organic |
IUPAC Name ![]() |
| 6-(cyclopropanecarbonylamino)-4-[3-(1-cyclopropyl-1,2,4-triazol-3-yl)-2-methoxyanilino]-N-(trideuteriomethyl)pyridazine-3-carboxamide |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 13300 | socrodeucitinib |
Synonyms ![]() |
| compound 1 [WO2022017494] |
Database Links ![]() |
|
| CAS Registry No. | 2457365-35-2 (source: WHO INN record) |
| GtoPdb PubChem SID | 518520694 |
| PubChem CID | 157020998 |
| Search Google for chemical match using the InChIKey | ZERZXBOGPOPJMF-FIBGUPNXSA-N |
| Search Google for chemicals with the same backbone | ZERZXBOGPOPJMF |
| Search PubMed clinical trials | socrodeucitinib |
| Search PubMed titles | socrodeucitinib |
| Search PubMed titles/abstracts | socrodeucitinib |
| UniChem Compound Search for chemical match using the InChIKey | ZERZXBOGPOPJMF-FIBGUPNXSA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | ZERZXBOGPOPJMF-FIBGUPNXSA-N |